CN101485865B - Chinese medicine fat-reducing plaster - Google Patents
Chinese medicine fat-reducing plaster Download PDFInfo
- Publication number
- CN101485865B CN101485865B CN2009100665080A CN200910066508A CN101485865B CN 101485865 B CN101485865 B CN 101485865B CN 2009100665080 A CN2009100665080 A CN 2009100665080A CN 200910066508 A CN200910066508 A CN 200910066508A CN 101485865 B CN101485865 B CN 101485865B
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- radix
- grams
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 239000011505 plaster Substances 0.000 title claims description 10
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 9
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 241000756943 Codonopsis Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 8
- 241000195474 Sargassum Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 4
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 4
- 208000008589 Obesity Diseases 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 8
- 235000020824 obesity Nutrition 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 235000003826 Artemisia Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 240000006891 Artemisia vulgaris Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000984231 Atractylodes chinensis Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 244000201986 Cassia tora Species 0.000 abstract 1
- 235000014552 Cassia tora Nutrition 0.000 abstract 1
- 241000195493 Cryptophyta Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000205407 Polygonum Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000009052 artemisia Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 22
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 210000001113 umbilicus Anatomy 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000001467 acupuncture Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229940097420 Diuretic Drugs 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine weight-reducing patch, and belongs to traditional Chinese medicine weight-reducing patches. The traditional Chinese medicine weight-reducing patch is prepared from the following bulk medicines in portion by weight: 25 to 35 portions of Astragalus membranaceus, 17 to 23 portions of Dangshen, 17 to 23 portions of Atractylodes macrocephaia, 17 to 23 portions of Atractylodes chinensis, 17 to 23 portions of Chinese thorowax roots, 17 to 23 portions of curcuma, 17 to 23 portions of Salvia miltiorrhiza, 17 to 23 portions of dried orange peels, 17 to 23 portions of hawkthorn, 17 to 23 portions of rhubarb, 17 to 23 portions of algae, 17 to 23 portions of Alisma orientale, 17 to 23 portions of lotus leaves, 17 to 23 portions of sicklesenna seeds, 17 to 23 portions of Poria cocos, 17 to 23 portions of pseudo-ginseng, 17 to 23 portions of corn stigma, 25 to 35 portions of Polygonum multiform, 25 to 35 portions of Artemisia capillaries and 2 to 4 portions of moschus. The traditional Chinese medicine weight-reducing patch has the efficacies of smoothing the liver and regulating qi, activating blood circulation to dissipate blood stasis, dredging channels and collaterals and reducing blood fat and weight, is used for treating simple obesity, and has the function of treating both principal and secondary aspect of diseases.
Description
Technical field
The invention belongs to a kind of Chinese medicine fat-reducing plaster.
Background technology
Along with growth in the living standard, people's life style has had very big change, and diet is more rich and varied, and some bad diet styles form day by day simultaneously, cause the serious deviation of body weight as food, gluttony crapulence, life is uncontrolled etc., athero forms obesity.
Adiposis patient is taken the Western medicine appetrol for a long time, side effect is very big, brings misery to patient, and it is high to cut back bounce-back rate, because the appetrol of being sold mostly are Western medicine preparation on the market, its main component has diuretic, thyroxine, ephedrine, cathartic, amphetamines, extender, chitin etc.Diuretic, increase is urinated, and side effect is vomiting, dizzy, physical weakness, electrolyte imbalance, and sequela is a lithangiuria.Thyroxine plays increases metabolic effect, and side effect is palpitating speed, hypertension (sequela has the excessive or overlong time of patient's taking dose to cause myocardial infarction).Ephedrine, it is an appetite-suppressing, side effect is that hypertension, insomnia and dreamful sleep, extremity are aching and limp, the long addiction that causes of Time of Administration.Cathartic increases defecation, and it is too short to reduce food time of staying in the intestines and stomach, and side effect is diarrhoea, stomachache, abdominal distention.Pacify non-its life, act on nervus centralis, appetite-suppressing, side effect is that anxiety, hallucination, insomnia, irritability, words are many.The swelling agent, the water absorption height makes the intestines and stomach that satiety be arranged, and the side effect meeting influences trace elements absorbed such as calcium, ferrum, zinc.
Treatment various diseases in umbilicus cave is in the existing thousands of years history of China, is the working people in the practice of struggling with disease, a kind of external treatment with Chinese medicine therapy of constantly summing up and growing up.For a long time, be that the patient of countless obesities removes fat misery with the effect of mystery and unique therapy.Scientific and modernized along with traditional traditional Chinese medical science, the combination of the therapy in umbilicus cave and modern physics therapy progressively improves umbilicus cave therapy, has formed a kind of miracle cure of uniqueness.Owing to have advantage easy and simple to handle, without any side effects, be subjected to obese patient's favor deeply.
Summary of the invention
The invention provides a kind of Chinese medicine fat-reducing plaster,, take the Western medicine fat-reducing with solution and bring the problem of side effect in order to cooperate umbilicus cave therapy.The technical scheme that the present invention takes is: be to be made by the crude drug of following ratio of weight and number: 25～35 parts of the Radixs Astragali, 17～23 parts of Radix Codonopsis, 17～23 parts of the Rhizoma Atractylodis Macrocephalaes, 17～23 parts of Rhizoma Atractylodis, 17～23 parts of Radix Bupleuri, 17～23 parts in Rhizoma Curcumae Longae, 17～23 parts of Radix Salviae Miltiorrhizaes, 17～23 parts of Pericarpium Citri Reticulataes, 17～23 parts of Fructus Crataegis, 17～23 parts of Radix Et Rhizoma Rhei, 17～23 parts of Sargassums, 17～23 parts of Rhizoma Alismatis, 17～23 parts on Folium Nelumbinis, 17～23 parts of Semen Cassiaes, 17～23 parts in Poria, 17～23 parts of Radix Notoginseng, 17～23 parts of Stigma Maydis, 25～35 parts of the Radixs Polygoni Multiflori, 25～35 parts of Herba Artemisiae Scopariaes, 2～4 parts in Moschus.
Preparation method of the present invention is that all medical materials are pulverized together, adopts traditional handicraft to make weight and is 9-12 gram plaster, and is standby with the aseptic plastic bag encapsulation.
Preferably:
30 parts of the Radixs Astragali, 20 parts of Radix Codonopsis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Rhizoma Atractylodis, 20 parts of Radix Bupleuri, 20 parts in Rhizoma Curcumae Longae, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Pericarpium Citri Reticulataes, 20 parts of Fructus Crataegis, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Sargassums, 20 parts of Rhizoma Alismatis, 20 parts on Folium Nelumbinis, 20 parts of Semen Cassiaes, 20 parts in Poria, 20 parts of Radix Notoginseng, 20 parts of Stigma Maydis, 30 parts of the Radixs Polygoni Multiflori, 30 parts of Herba Artemisiae Scopariaes, 3 parts in Moschus.
The Radix Astragali has the effect of QI invigorating detoxifcation in the side, and Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Poria have invigorating the spleen and benefiting QI, interior can be drying damp and strengthening spleen, can disperse effects such as rheumatism outward, Rhizoma Curcumae Longae, Radix Salviae Miltiorrhizae, Radix Notoginseng, Radix Bupleuri, Moschus have logical all keys, open meridians, blood circulation promoting and blood stasis dispelling, energy tonneau muscle arteries and veins, internal energy tonneau QI and blood; Sargassum, Pericarpium Citri Reticulatae, Fructus Crataegi, Rhizoma Alismatis, Folium Nelumbinis, Stigma Maydis, Herba Artemisiae Scopariae have regulating QI of the middle-JIAO, drying dampness to eliminate phlegm, heat clearing away, lowering blood-fat and reducing weight; Radix Et Rhizoma Rhei, the Radix Polygoni Multiflori have effects such as purging fire and cooling blood, loosening bowel to relieve constipation; Semen Cassiae has effects such as liver heat removing and eyesight improving.
The present invention has depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling, meridians dredging, the effect of lowering blood-fat and reducing weight.Be used for the treatment of Simple Obesity, play the effect for the treatment of both the principal and secondary aspects of a disease.During use, the present invention is affixed on patient's umbilicus cave.
Theory of Chinese medical science it is generally acknowledged that obesity is the disease of deficiency in origin and excess in superficiality, natural endowment, surfeit delicious food savoury, internal injury caused by excess of seven emotions and sitting several big principal elements institute such as crouch well is inseparable, obesity mainly since dysfunction of the spleen in transportation cause, simultaneously relevant with liver, kidney, lung, the heart etc., so we develop the present invention at various diseases, mainly control with five kinds of formalisms: 1, control from the spleen opinion; 2, control from the liver opinion; 3, control from the kidney opinion; 4, control from the phlegm-damp opinion; 5, comprehensive qi stagnation blood stasis type opinion is controlled.Cooperate traditional Chinese medical science acupoint therapy, because the umbilicus acupuncture point is in the abdominal part center, it is hands three cloudy and foot three cloudy six meridians junctions, and meridians are majors avenues of approach of QI-blood circulation in the body, the needed nutrient substance of each internal organs organ-tissue all transports by channel system and distributes, so acupuncture point on every side is numerous, thereby open Conception Vessel and Governor Vessel, make the efficacy of a drug pass through the acupuncture point percdation, play fat-eliminating slimming, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling plays the effect of endocrine regulation imbalance and gynecological inflammation, simultaneously to hypertension, cerebral arteriosclerosis, coronary heart disease, fatty liver also has magical curative effect, meanwhile, also thoroughly remove the misery that adiposis patient is taken Western medicine for a long time.
Clinical report: with we treatment 205 examples, age 16-65 year, 45 years old mean age, course of disease 1-20, relevant 70 examples of falling ill with diet, 80 examples relevant, 18 examples relevant with puerperal with heredity, 5 examples relevant with postoperative reduce 26 relevant examples, agnogenic 6 examples with activity; Severe obesity wherein, body weight surpasses 100 kilograms 50 examples, wherein is merged into hypertensive 50 examples, 20 examples of hyperlipidemia, 15 examples of coronary heart disease, 10 examples of edema.
Result's 15 days produce effects in 205 examples of the present invention treatment:
40 examples that conscious disease alleviates lose weight 9 kilograms;
Effective subjective symptoms 13 kilograms 80 examples of obviously alleviating, lose weight;
Specific, body weight descended 16 kilograms within 15 days 82 examples;
Invalid: conscious disease does not have significant change, and 3 kilogram of 3 example loses weight.
The present invention with body weight in 15 days, descend be no more than 3 kilograms for invalid, total effective rate reaches 98.5%.
In addition the present invention to season the property sent out obesity better curative effect is also arranged, to losing weight and controlling related complication certain curative effect is arranged, show according to clinical experiment: most of drug action mechanism is arranged in the we, has the drainage that promotes enteral fat, control, absorption, inhibition serum, cholesterol, triglyceride and lipoprotein anabolic effect.
The specific embodiment
Embodiment 1
The Radix Astragali 25 grams, Radix Codonopsis 17 grams, the Rhizoma Atractylodis Macrocephalae 17 grams, Rhizoma Atractylodis 17 grams, Radix Bupleuri 17 grams, Rhizoma Curcumae Longae 17 grams, Radix Salviae Miltiorrhizae 17 grams, Pericarpium Citri Reticulatae 17 grams, Fructus Crataegi 17 grams, Radix Et Rhizoma Rhei 17～23 grams, Sargassum 17 grams, Rhizoma Alismatis 17 grams, Folium Nelumbinis 17 grams, Semen Cassiae 17 grams, Poria 17 grams, Radix Notoginseng 17 grams, Stigma Maydis 17 grams, the Radix Polygoni Multiflori 25 grams, Herba Artemisiae Scopariae 25 grams, Moschus 2 grams.
Preparation method of the present invention is that all medical materials are pulverized together, adopts traditional handicraft to make weight and is 9 gram plaster, and is standby with the aseptic plastic bag encapsulation.
Embodiment 2
The Radix Astragali 30 grams, Radix Codonopsis 20 grams, the Rhizoma Atractylodis Macrocephalae 20 grams, Rhizoma Atractylodis 20 grams, Radix Bupleuri 20 grams, Rhizoma Curcumae Longae 20 grams, Radix Salviae Miltiorrhizae 20 grams, Pericarpium Citri Reticulatae 20 grams, Fructus Crataegi 20 grams, Radix Et Rhizoma Rhei 20 grams, Sargassum 20 grams, Rhizoma Alismatis 20 grams, Folium Nelumbinis 20 grams, Semen Cassiae 20 grams, Poria 20 grams, Radix Notoginseng 20 grams, Stigma Maydis 20 grams, the Radix Polygoni Multiflori 30 grams, Herba Artemisiae Scopariae 30 grams, Moschus 3 grams.
Preparation method of the present invention is that all medical materials are pulverized together, adopts traditional handicraft to make weight and is 10 gram plaster, and is standby with the aseptic plastic bag encapsulation.
Embodiment 3
The Radix Astragali 35 grams, Radix Codonopsis 23 grams, the Rhizoma Atractylodis Macrocephalae 23 grams, Rhizoma Atractylodis 23 grams, Radix Bupleuri 23 grams, Rhizoma Curcumae Longae 23 grams, Radix Salviae Miltiorrhizae 23 grams, Pericarpium Citri Reticulatae 23 grams, Fructus Crataegi 23 grams, Radix Et Rhizoma Rhei 23 grams, Sargassum 23 grams, Rhizoma Alismatis 23 grams, Folium Nelumbinis 23 grams, Semen Cassiae 23 grams, Poria 23 grams, Radix Notoginseng 23 grams, Stigma Maydis 23 grams, the Radix Polygoni Multiflori 35 grams, Herba Artemisiae Scopariae 35 grams, Moschus 4 grams.
Preparation method of the present invention is that all medical materials are pulverized together, adopts traditional handicraft to make weight and is 12 gram plaster, and is standby with the aseptic plastic bag encapsulation.
Claims (2)
1. a Chinese medicine fat-reducing plaster is characterized in that: be to be made by the crude drug of following ratio of weight and number: 25～35 parts of the Radixs Astragali, 17～23 parts of Radix Codonopsis, 17～23 parts of the Rhizoma Atractylodis Macrocephalaes, 17～23 parts of Rhizoma Atractylodis, 17～23 parts of Radix Bupleuri, 17～23 parts in Rhizoma Curcumae Longae, 17～23 parts of Radix Salviae Miltiorrhizaes, 17～23 parts of Pericarpium Citri Reticulataes, 17～23 parts of Fructus Crataegis, 17～23 parts of Radix Et Rhizoma Rhei, 17～23 parts of Sargassums, 17～23 parts of Rhizoma Alismatis, 17～23 parts on Folium Nelumbinis, 17～23 parts of Semen Cassiaes, 17～23 parts in Poria, 17～23 parts of Radix Notoginseng, 17～23 parts of Stigma Maydis, 25～35 parts of the Radixs Polygoni Multiflori, 25～35 parts of Herba Artemisiae Scopariaes, 2～4 parts in Moschus.
2. a kind of Chinese medicine fat-reducing plaster according to claim 1 is characterized in that: be to be made by the crude drug of following ratio of weight and number: 30 parts of the Radixs Astragali, 20 parts of Radix Codonopsis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Rhizoma Atractylodis, 20 parts of Radix Bupleuri, 20 parts in Rhizoma Curcumae Longae, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Pericarpium Citri Reticulataes, 20 parts of Fructus Crataegis, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Sargassums, 20 parts of Rhizoma Alismatis, 20 parts on Folium Nelumbinis, 20 parts of Semen Cassiaes, 20 parts in Poria, 20 parts of Radix Notoginseng, 20 parts of Stigma Maydis, 30 parts of the Radixs Polygoni Multiflori, 30 parts of Herba Artemisiae Scopariaes, 3 parts in Moschus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100665080A CN101485865B (en) | 2009-02-11 | 2009-02-11 | Chinese medicine fat-reducing plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100665080A CN101485865B (en) | 2009-02-11 | 2009-02-11 | Chinese medicine fat-reducing plaster |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101485865A CN101485865A (en) | 2009-07-22 |
| CN101485865B true CN101485865B (en) | 2011-06-29 |
Family
ID=40889026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100665080A Expired - Fee Related CN101485865B (en) | 2009-02-11 | 2009-02-11 | Chinese medicine fat-reducing plaster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101485865B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552884B (en) * | 2012-03-20 | 2013-11-06 | 南宁市品迪生物工程有限公司 | Weight loss secret recipe of Zhuang medicine |
| CN102886038B (en) * | 2012-10-15 | 2014-01-01 | 王彦进 | Traditional Chinese medicine preparation for losing weight and preparation method of traditional Chinese medicine preparation |
| CN103142871A (en) * | 2013-02-08 | 2013-06-12 | 安耀苍 | Obesity treatment medicine and its preparation method |
| CN104338030A (en) * | 2013-08-07 | 2015-02-11 | 蔡明华 | Herbal composition suitable for navel sticking-method weight losing and preparation method thereof, |
| CN103611082A (en) * | 2013-11-28 | 2014-03-05 | 刘菊 | Weight-reducing traditional Chinese medicine composition |
| CN103751730B (en) * | 2014-02-22 | 2015-10-07 | 储可英 | A kind of medicine for the treatment of simple obesity and preparation method thereof |
| CN103977349A (en) * | 2014-05-22 | 2014-08-13 | 上海有美健康咨询中心 | Traditional Chinese medicine enema for treating obesity |
| CN104886298A (en) * | 2015-05-29 | 2015-09-09 | 安徽广生堂生物科技有限公司 | Method for preparing diet tea by utilizing Chinese herbal medicines and brown rice |
| CN105410927A (en) * | 2015-10-30 | 2016-03-23 | 郭长合 | Plant-source food capable of reducing weight and preparation method of plant-source food |
| CN105832861A (en) * | 2016-06-01 | 2016-08-10 | 尹金明 | Traditional Chinese medicine navel protection pad for weight losing and body conditioning and preparation method and application of traditional Chinese medicine navel protection pad |
| CN105943773A (en) * | 2016-06-23 | 2016-09-21 | 河南中医学院 | Traditional Chinese medicine acupoint plaster for simple obesity |
| CN106620516A (en) * | 2016-12-07 | 2017-05-10 | 庞秀军 | Traditional Chinese medicine composition used for health maintenance and weight loss as well as preparation and preparation method thereof |
| CN107596322A (en) * | 2017-10-19 | 2018-01-19 | 向洪庆 | A kind of thermal pack of fat-reducing |
| CN109172787A (en) * | 2018-09-25 | 2019-01-11 | 广西中医药大学 | A kind of graphene fat-reducing plaster and preparation method thereof |
| CN108992558A (en) * | 2018-10-11 | 2018-12-14 | 张艳 | A kind of traditional Chinese medicine capable of reducing weight is applied with formula and preparation method thereof |
| CN109692324B (en) * | 2019-03-25 | 2019-06-25 | 江西中医药大学 | It is a kind of to disappear the Chinese medicine hydrogel emplastrum and preparation method thereof of rouge for subtracting tripe |
| CN110507755A (en) * | 2019-10-16 | 2019-11-29 | 冯焱 | A kind of slim acupoint plaster |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1102549A (en) * | 1994-08-30 | 1995-05-17 | 伏慎跃 | Fat reducing healthy foods |
| CN1105557A (en) * | 1994-10-11 | 1995-07-26 | 吴宏伟 | Method for preparation of weight-loosing medicine and its products |
| CN1107691A (en) * | 1994-03-02 | 1995-09-06 | 赵新胜 | Slimming and life-prolonging natural health bath lotion and its preparation |
| CN1280835A (en) * | 2000-04-21 | 2001-01-24 | 张印文 | Chinese-medicinal capsule for treating hyperlipomia |
| CN101195001A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for treating hypertension, hypercholesterolemia and hyperglycemia |
-
2009
- 2009-02-11 CN CN2009100665080A patent/CN101485865B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1107691A (en) * | 1994-03-02 | 1995-09-06 | 赵新胜 | Slimming and life-prolonging natural health bath lotion and its preparation |
| CN1102549A (en) * | 1994-08-30 | 1995-05-17 | 伏慎跃 | Fat reducing healthy foods |
| CN1105557A (en) * | 1994-10-11 | 1995-07-26 | 吴宏伟 | Method for preparation of weight-loosing medicine and its products |
| CN1280835A (en) * | 2000-04-21 | 2001-01-24 | 张印文 | Chinese-medicinal capsule for treating hyperlipomia |
| CN101195001A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for treating hypertension, hypercholesterolemia and hyperglycemia |
Non-Patent Citations (4)
| Title |
|---|
| 卫生部.减肥通圣片.《卫生部颁药品标准中药成分制剂第十九册》.1998,175. * |
| 卫生部.轻身减肥片.《卫生部颁药品标准中药成方制剂第十九册》.1998,135. * |
| 卫生部.降脂减肥片.《卫生部颁药品标准中药成方制剂第十七册》.1998,167. * |
| 国家药监局.降脂排毒胶囊.《国家药品中药标准内科心系分册》.2002,202. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101485865A (en) | 2009-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101485865A (en) | Chinese medicine fat-reducing plaster | |
| CN1723926A (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN102430079B (en) | Traditional Chinese medicine composite for treating stranguria | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN100497578C (en) | Nourishing health-care medicated wine | |
| CN102488844B (en) | Traditional Chinese medicine for regulating function of spleen and kidney | |
| CN105056124A (en) | Medicine for treating hypertension and diabetes | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN103110762A (en) | Traditional Chinese medicine composition for treating old fracture | |
| CN102512632A (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN103007077B (en) | Chinese medicinal composition for treating climacteric syndrome | |
| CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
| CN101428114B (en) | Medicament for treating chronic hepatitis B, cirrhosis and liver ascites | |
| CN102895610A (en) | Medicine for treating edema | |
| CN101757421A (en) | Traditional Chinese medicine composite for treating obesity | |
| CN104258351A (en) | Traditional Chinese medicine preparation for treating alcoholic cardiomyopathy and preparation method of preparation | |
| CN103550616A (en) | Traditional Chinese medicinal prescription for treating diabetic gangrene | |
| CN1224416C (en) | Chinese medicine for treating keloid | |
| CN103239656A (en) | Traditional Chinese medicine for treating psoriasis | |
| CN101095938A (en) | Chinese traditional medicine for treating diabetic ischemic muscular atrophy | |
| CN112294928A (en) | A Chinese medicinal composition for treating diabetes, and its preparation method | |
| CN105126022A (en) | Medicine for treating ichthyosis and preparation method of medicine | |
| CN105288417A (en) | Traditional Chinese medicine for treating infantile malnutrition | |
| CN101264225B (en) | Orally-administered decoction for treating ulcer in tongue base | |
| CN103656565A (en) | Drug for treating Qi and Yin deficiency type myocardial infarction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20150211 |
|
| EXPY | Termination of patent right or utility model |